SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001214659-24-007805
Filing Date
2024-04-30
Accepted
2024-04-29 21:49:44
Documents
18

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 p426240posam1.htm   iXBRL POS AM 564362
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 7002
3 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
4 GRAPHIC chart.jpg GRAPHIC 83827
5 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
  Complete submission text file 0001214659-24-007805.txt   1244327

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bdrx-20240429.xsd EX-101.SCH 19349
7 XBRL DEFINITION FILE bdrx-20240429_def.xml EX-101.DEF 26950
8 XBRL LABEL FILE bdrx-20240429_lab.xml EX-101.LAB 83863
9 XBRL PRESENTATION FILE bdrx-20240429_pre.xml EX-101.PRE 25602
21 EXTRACTED XBRL INSTANCE DOCUMENT p426240posam1_htm.xml XML 6805
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-278040 | Film No.: 24893764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)